Which has the lower trailing P/E, DXCM or IDXX?

DXCM has the lower trailing P/E: DXCM trades at 32.98 and IDXX at 41.23. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DXCM or IDXX?

Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus IDXX at 9.24%.

Is DXCM or IDXX more profitable?

IDXX runs the higher net margin — DXCM at 20.12% versus IDXX at 24.63%.

How have DXCM and IDXX total returns compared?

Over the past 10 years, DXCM delivered 13.72% and IDXX delivered 19.54% annualized total return. Past performance doesn't predict future results.

DexCom, Inc. (DXCM) vs IDEXX Laboratories, Inc. (IDXX)

A side-by-side comparison of DexCom, Inc. and IDEXX Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.

DXCM

DexCom, Inc.

$32.20B

$83.45HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

IDXX

IDEXX Laboratories, Inc.

$44.10B

$559.07HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

Total return — DXCM vs IDXX

growth of $100 · dividends reinvested · last 21y

DXCM +2738.4%IDXX +4035.1%IDXX compounded faster

DXCM IDXX

DXCM vs IDXX: by the numbers

•IDXX is the larger company ($44.10B vs $32.20B market cap).
•DXCM trades at the lower trailing earnings multiple (32.98 vs 41.23 P/E), one valuation lens rather than an overall verdict.
•IDXX converts more revenue to profit (24.63% vs 20.12% net margin).
•DXCM grew revenue faster over the past five years (18.03% vs 9.24% CAGR).

Metrics side by side

Valuation

Metric	DXCM	IDXX
P/E ratio	32.98	41.23
Forward P/E	31.86	38.17
P/S ratio	6.58	10.14
P/B ratio	12.47	28.98
PEG ratio	0.67	2.31
EV / EBITDA	25.98	29.59
FCF yield	4.30%	2.39%

Profitability

Metric	DXCM	IDXX
Gross margin	62.79%	62.05%
Operating margin	22.92%	31.63%
Net margin	20.12%	24.63%
ROE	38.14%	70.38%
ROIC	16.61%	40.27%

Growth (annualized)

Metric	DXCM	IDXX
Revenue CAGR (5Y)	18.03%	9.24%
EPS CAGR (5Y)	10.31%	14.07%
FCF CAGR (5Y)	69.49%	10.13%
Total return CAGR (5Y)	-8.32%	-3.80%

Frequently asked

Which has the lower trailing P/E, DXCM or IDXX?: DXCM has the lower trailing P/E: DXCM trades at 32.98 and IDXX at 41.23. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DXCM or IDXX?: Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus IDXX at 9.24%.
Is DXCM or IDXX more profitable?: IDXX runs the higher net margin — DXCM at 20.12% versus IDXX at 24.63%.
How have DXCM and IDXX total returns compared?: Over the past 10 years, DXCM delivered 13.72% and IDXX delivered 19.54% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DXCM analysis Full IDXX analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio IDEXX Laboratories P/E ratio DexCom dividend yield IDEXX Laboratories dividend yield DexCom ROE IDEXX Laboratories ROE DexCom operating margin IDEXX Laboratories operating margin DexCom revenue growth IDEXX Laboratories revenue growth DexCom free cash flow IDEXX Laboratories free cash flow

DexCom & IDEXX Laboratories appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.